KSHB - KushCo Holdings, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
3.0900
-0.1300 (-4.04%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close3.2200
Open3.1600
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range2.9000 - 3.2000
52 Week Range2.9000 - 7.2000
Volume941,039
Avg. Volume426,112
Market Cap274.516M
Beta (3Y Monthly)1.63
PE Ratio (TTM)N/A
EPS (TTM)-0.3840
Earnings DateJul 9, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est8.13
Trade prices are not sourced from all markets
  • GlobeNewswire

    Investor Ideas Potcast- Cannabis News and Stocks on the Move; You Can’t Keep a Good Plant Down- Thought Leaders Share High Expectations for Cannabis Sector

    When asked about the recent announcement involving Convectium/Jacksam, Mr. Ralston commented, "Convectium was founded on the basis that automation, speed, hardware and technology combined for the ancillary cannabis space can really help these manufacturers and retailers make their whole filling and supply chain process much simpler and efficient. Discussing what separates Convectium from some of their competitors, Ralston said, "Right now Convectium, in our opinion, is really leading the way because they check all the boxes for what a company may need when it comes to filling and getting these automation systems set up. SinglePoint Inc. will also be presenting their Pure Hemp Cigarettes next month at NACS on October 1st - 4th at booth 5653.

  • PR Newswire

    Cannabis Virtual Investor Conference Presentations Now Available for On-Demand Viewing

    Individual and institutional investors as well as advisors are invited to log-on to VirtualInvestorConferences.com to view the presentations NEW YORK , Sept. 16, 2019 /PRNewswire/ -- Virtual Investor Conferences ...

  • ACCESSWIRE

    KushCo Holdings Enters Exclusive Distribution Agreement with De La Rue to Authenticate Products Throughout the Supply Chain

    "Company views product offering as a critical step in combatting the black market and illicit operators" GARDEN GROVE, CA / ACCESSWIRE / September 16, 2019 / KushCo Holdings, Inc. (OTCQX:KSHB) ...

  • ACCESSWIRE

    KushCo Holdings, Inc. Reconfirms Fiscal 2019 Revenue Guidance

    GARDEN GROVE, CA / ACCESSWIRE / September 13, 2019 / KushCo Holdings, Inc. (KSHB) (“KushCo” or the “Company”), today announced that it is reconfirming its annual revenue guidance for its fiscal year ended August 31, 2019 of between $145 million and $150 million in sales. The Company renamed and rebranded itself as “KushCo Holdings, Inc.” The Company’s main operating company subsidiary is now Kush Supply Co. The Company opened its new corporate headquarters in Cypress, California.

  • 7 Marijuana Stocks With Critical Levels to Watch
    InvestorPlace

    7 Marijuana Stocks With Critical Levels to Watch

    [Editor's note: This story will be updated each week with new stocks and analysis. Please check back often for Mark's latest take on marijuana stocks.]In financial markets certain levels are more important than others with respect to the amount of supply and demand that exists within them. In addition, financial market prices are always doing one of three things. They are either going up, going down or staying the same. When applied correctly, technical analysis of marijuana stocks should help you identify the important levels and trends in this sector.Understanding these dynamics will help you make money. For instance, suppose you want to buy a stock if it drops to the $10 level. Your plan may not work if you don't understand the current market dynamics. There may be significant support at the $11 level. The stock may fall but not get to $10. It may find support around $11 and then rally. Because you didn't know where the support was, you lost out on a chance to make money for one dollar.InvestorPlace - Stock Market News, Stock Advice & Trading TipsThere was important news for the industry that no one seems to be talking about. The Office of the Attorney General said that it will begin processing applications to research cannabis. As of right now, the University of Mississippi is the only institution in the United States that is currently allowed to do so. The DEA said that it wants to improve access to marijuana research. This is a major step down the path toward legalization on a Federal Level. * 10 Battered Tech Stocks to Buy Now This news could be the reason why many of the stocks in this industry have broken their recent downtrends and have been consolidating. Aurora Cannabis Inc (ACB)Aurora Cannabis Inc (NYSE:ACB) is a Canadian-based company that grows and sells medical marijuana, indoor cultivation systems and hemp-related food products.ACB broke its downtrend after finding support around the $5.50 level. If this level breaks and it goes lower, look for support around the $5 level. This is where the lows were in December and January.If the stock trades higher, there is a good chance that it will hit resistance around the $7 level. This level was resistance in August. It was also support in June and July.Why would a prior level that was support become a resistance level? One of the reasons is because the people who bought it at $7 when it was support are now looking at losses. They tell themselves that if the stock trades back up to the $7 level, they will sell it to get out at breakeven. This supply of stock at the level creates resistance. Cronos Group Inc (CRON)Cronos Group Inc (NASDAQ:CRON) grows and sells marijuana.CRON stock has broken its recent downtrend and has been consolidating above support around the $10.75 level. If it rallies there will probably be resistance around the $14 level. It was a support level from May through late July.It seems to me like CRON stock will continue to consolidate in the short-term. It is in the middle of a range and the momentum is neutral.An interesting but largely ignored dynamic with this stock is that by consummating its deal with Altria (NYSE:MO) CRON effectively became a sin stock. These are stocks of companies that engage in what some would consider unethical behavior. Altria, AKA Phillip Morris, certainly fits the description. * The 7 Stocks Hedge Funds Are Buying Big Because of this certain institutional money managers that have ESG concerns will not be able to invest in the stock. This could put it at a disadvantage to its competitors. Canopy Growth Company (CGC)Canopy Growth (NYSE:CGC) grows and sells marijuana.CGC stock broke its recent downtrend and has been consolidating around the $27 level.If it heads lower, there is a good chance that it will find support around $23. This is where it recently found a low before rallying. The people who wanted to buy at $23 and didn't tell themselves that if it drops back to $23, they will buy it.Those who shorted it at $23 are now looking at a loss. They tell themselves that if the stock drops back and they can get out of it at breakeven, they will cover at $23. Added to this are professional traders that want to profit off of a clearly defined level and you can understand why a prior support level could be support again.If CGC heads higher there is a good chance that it will run into resistance around the $32 level. This level was support in the first half of August. KushCo Holdings, Inc. (KSHB)KushCo Holdings, Inc. (OTCMKTS:KSHB) sells packaging supplies.KSHB stock has broken its recent downtrend and has been consolidating around the $3.75 level.Consolidating or trading sideways are terms that refer to markets that are in equilibrium. In other words, the forces of supply are equal with the forces of demand.When stocks are in a downtrend, the forces of supply are stronger than the forces of demand. When markets are trending higher the forces of demand are overpowering the forces of supply. * The 10 Best Index Funds to Buy and Hold When trendlines are properly understood and drawn correctly, a trendline break could mean that the control of the market is about to change. In the situation here when the red downtrend line broke, it was an early indication that the selloff was about to come to an end. The stock has been trading sideways since then. HEXO Corp (HEXO)HEXO Corp (NYSE:HEXO) grows and sells medical marijuana.HEXO recently found support around the $3.80 level. This level will probably be support again if it heads lower. The stock may have formed a reversal pattern, which would mean that it is about to head lower.The stock rallied everyday from Aug. 30 through Sept. 6. Each day, the closing price was higher than the opening price. These days are blue on the chart. The days when the closing price was lower than the opening price are red.Then on Sept. 9 something happened which could mean that the forces of supply are about to take leadership over from the forces of demand.You can see that the stock opened at what was the high price of the day. Then it sold off over the course of the day and closed at its lows (this is represented by the big red line). This pattern could mean that the sellers are about to take control of the market. Innovative Industrial Properties (IIPR)Innovative Industrial Properties (NYSE:IIPR) manages industrial properties and leases them to licensed medical marijuana growers.IIPR is consolidating below the important $90 level. This level is important because it was a resistance level from last March through June. Then, when the market saw some dramatic selling two weeks ago, it is where the stock found a floor. Since then, it slowly traded through the level and has been consolidating below it.Why would a level that was prior resistance become support? Those who bought it there and those who wanted to buy it but didn't each told themselves they will acquire shares if it drops back to the level. * 7 Strong-Buy Stocks Hedge Funds Are Buying Now Those who are short were feeling pretty good when it went lower. But after the stock rallied and broke $90 to the upside they are losing money. They say to themselves that they will buy it back at $90 if they can, so they can close out of their position without losing money. This demand for the stock at the $90 level is what creates support. Medicine Man Technologies, Inc. (MDCL)Medicine Man Technologies, Inc. (OTCMKTS:MDCL) provides cultivation consulting services to cannabis growers.MDCL stock is overbought and it is approaching a level that has been resistance before. We will probably see some profit taking or consolidation.The levels around $3.90 were the top in April, and then again in May and June. In addition, MDCL stock is the most overbought that it has been since April.Overbought refers to the momentum. Momentum is where the price is today versus where it was X many days ago. When this number reaches an extreme to the upside, it is considered to be overbought.This is an important dynamic to understand about markets. When they are oversold and get to support, they tend to rebound. When markets are overbought and get to resistance, they tend to selloff.As of this writing, Mark Putrino did hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Battered Tech Stocks to Buy Now * 7 Strong-Buy Stocks Hedge Funds Are Buying Now * The 7 Best Penny Stocks to Buy The post 7 Marijuana Stocks With Critical Levels to Watch appeared first on InvestorPlace.

  • CNW Group

    /R E P E A T -- Live Investor Conference & Webinar: Cannabis Industry Companies Present September 12th/

    /R E P E A T -- Live Investor Conference & Webinar: Cannabis Industry Companies Present September 12th/

  • This Marijuana Stock Is Well-Positioned for a Comeback
    TipRanks

    This Marijuana Stock Is Well-Positioned for a Comeback

    KushCo Holdings (KSHB) has lagged most of its peers in the past months, as some internal problems and the weakening sentiment for the broader market has caused investors to run to safer plays.That combined with the industry taking a black eye from the CannTrust debacle and fall from favor of Canopy growth, as resulted in the company struggling to gain momentum.Consequently, it has one of the most inexpensive forward price-to-sales ratios in the cannabis sector based upon consensus sales of $242.5 million next year, making its valuation under 1.8x 2020's projected revenue.While the industry and the company aren't out of the woods yet, KushCo is positioned to make a nice upward run when sentiment changes.KushCo has a small, but vocal camp of bullish analysts with positive expectations for its stock. Out of the 3 analysts polled by TipRanks, all 3 rate KSHB a Buy. With a return potential of 105%, the stock's 12-month consensus target price stands at $7.67. (See KSHB's price targets and analyst ratings on TipRanks) Internal challengesA couple of things that have weighed on the company are its need to restate its accounting results, and its fairly recent failure to meet delivery expectations concerning compliant packaging to the Canadian market, which was part of the reason for a bottleneck in the supply chain.What happened concerning the accounting errors was the company had to restate its 2017 and 2018 financial results, causing the market to rightfully question the capability of management.Taken together with some of the negative issues associated with the cannabis industry, along with growing concerns over whether or not the economy is slowing down, it has brought about a disproportionate response from the market toward KushCo, in my opinion.With its fast-growing vaporizer segment and increasing its hydrocarbon gases and solvents unit, the company has diversified its portfolio to the point any weakness in one unit should be offset by strength in another.The good news to me is the issues KushCo has faced shouldn't have any problem being solved. That's important because its vaporizer unit should enjoy increasing sales from the Canadian market in 2020 after Canada allows sales of derivative products, of which vaporizers is one of the more popular.That and the highly fragmented compliance requirements in various municipalities in the U.S., provide a solid long-term growth opportunity for KushCo. Even if there is eventually more uniformity concerning future requirements, it'll take a long time to play out.Also, it works with cannabis growers in 25 countries concerning packaging and branding compliance, making it a potentially very lucrative segment to compete in.Canadian derivativesEven though a number of derivatives will be legalized in Canada during October, it'll take until the last couple of weeks of December 2019 before they will be rolled out. For that reason KushCo and others won't get much immediate benefit from it until the first calendar quarter of 2020.With a solid vaporizer unit, KushCo is well positioned to generate significant revenue from legalization in the Canadian market, as it's one of the more popular ways to consume cannabis in the country.This should help the bottom line of KushCo, which in the last quarter fell to a net loss of $10.6 million, down from the $9.2 million loss in the same reporting period last year.The reason why that should improve is vaporizers and other derivative products command higher prices and margins.With its consistent revenue growth, which in the last quarter soared to $41.5 million, a gain of 221 percent year-over-year, the company would get a huge boost in its share price if it is able to continue to grow sales while showing a clear path to profitabilty in the not-too-distant future.As for its hydrocarbon gases and solvents division, that will probably take longer to grow, but with gas in particular being used in the production process of oils - which also generate higher prices and margins - the company has a connection to the oils market that should be a solid niche market in the future.ConclusionKushCo has been a victim of its own accounting errors and temporary failure to deliver on expected compliant packaging in the past. I think both of those are easily solvable, and we should hear from the company that they are problems it has solved.The cannabis market is still under some pressure from the various perceived economic issues at the global level, but it appears the sentiment is improving some, and once that turns around and the market starts to see the potential growth trajectory of KushCo, along with the supplying of new products that will bring it closer to profitability, it's going to be considered one of the most undervalued cannabis stocks available.As the cannabis market sits today, which should last long into the future, KushCo, assuming it executes well, has the product lines in place to enjoy a long upward growth in sales, which will ultimately be done at a profit. I think patient investors are going to be rewarded well.The one caveat is it must show it has control of its accounting numbers in the future. Any further failure there would make it hard for the company to retain faith in its competence.Visit TipRanks’ Trending Stocks page, and find out what companies Wall Street’s top analysts are looking at now.Disclosure: None

  • Benzinga

    3 Reasons To Consider Investing In Cannabis

    As investors, traders and followers of the markets, we can all look back and lament the Apple stock (or the proverbial stock fish of your choice) that got away. Want to learn more about cannabis stocks and where the industry is headed? The cannabis industry is big now, and it’s going to be a lot larger than many realize.

  • PR Newswire

    KushCo Holdings to Webcast Live at VirtualInvestorConferences.com Sept. 12th

    GARDEN GROVE, Calif. , Sept. 9, 2019 /PRNewswire/ -- KushCo Holdings, Inc. (OTCQX: KSHB) (''KushCo'' or the ''Company''), today announced that Nick Kovacevich , Chief Executive Officer and Chairman, will ...

  • 5 Top Small-Cap Marijuana Stocks to Buy for the Long Term
    Motley Fool

    5 Top Small-Cap Marijuana Stocks to Buy for the Long Term

    These under-the-radar pot stocks could run circles around their larger peers.

  • 3 Unusual Cannabis Plays To Track Now
    TipRanks

    3 Unusual Cannabis Plays To Track Now

    Since Canada enacted nation-wide legalization of marijuana in October 2018, cannabis companies have been the hot new thing in stock investing. But sometimes, that hot new thing isn’t always hot. The cannabis sector has seen a sharp decline in recent months. Major players, like Canopy Growth (CGC) and Aurora Cannabis (ACB), are down by a third or more since the spring. The reasons are varied – licensing bottlenecks in Health Canada, supply and distribution difficulties in a new market, management turnover at Canopy – but the result is clear: the big cannabis companies are not delivering results so far.But there is still money to be made in the cannabis industry. The product is in demand; the problems the big suppliers face are more in the nature of growing pains. So, to profit, investors will benefit by thinking outside of the grow house. We’ve dipped into TipRanks’ stock database and found three companies that are thriving as service providers for the cannabis industry. Innovative Industrial Properties (IIPR)This company is a Real Estate Investment Trust (REIT), focused on the cannabis industry. Innovative buys and manages industrial properties which it then leases to cannabis growers. It’s a profitable model, and the company’s Q2 earnings result bear that out. IIRP reported gains of 155% in both revenues and net income, with the former coming in at $8.28 million and the latter at $3.07 million. EPS, at 30 cents, was up 76%.According to Exec. Chairman Alan Gold, IIPR has operations in 26 states, with over 2 million square feet leased long-term to cannabis growers. The average remaining lease term is over 15 years, and the properties have a current blended yield of 14.6%. CEO Paul Smithers noted that industry analysts see plenty of momentum in cannabis. In his comments on the earnings, he quoted sources projecting “a 35% increase in US regulated cannabis sales from 2018 to 2019, and reaching nearly $30 billion by 2023.” The current operations, and the prospects for near-term growth, provide IIPR with both a solid foundation and an upbeat outlook.In an added boon for investors, IIPR has been paying out a quarterly dividend over the past two years, with regular increases in the disbursement. The current yield is 2.16%, and the payment is $1.80 annualized. The July quarterly payment of 60 cents per share marked a 140% increase year-over-year.Right now, IIPR has one analyst rating, from James Sullivan of BTIG. Sullivan, a 4-star analyst, leads the REIT research team at BTIG. He gives IIPR a $151 price target, suggesting an impressive 81% upside. It’s a clear sign of confidence in the real estate aspect of the cannabis industry. Scotts Miracle-Gro Company (SMG)Land is important, but cannabis industry relies on increasing production and multiple harvests per year to maximize revenue. This requires greenhouses and other controlled growing facilities – letting the plants grow wild outdoors simply won’t cut it. And greenhouses are where Scotts Miracle-Gro comes in.The company may be best known for its Miracle-Gro weed killer and other home gardening products, but its Hawthorne subsidiary is deeply involved in the cannabis industry. Where IIPR provides the real estate needed by the growers, Scotts provides the hydroponic and lighting systems necessary for large-scale indoor cultivation of cannabis. In fact, the company’s annual sales growth of hydroponic systems has outpaced that of traditional lawn and garden gear for the last three years. In a 2016 interview, CEO Jim Hagedorn laid out a vision of marijuana ancillary products as the future of his company: “We’re doing it. It’s beyond stopping. And we’re not getting into pot growing. We’re talking dirt, fertilizer, pesticides, growing systems, lights. You know it’s a multibillion-dollar business...”Hagedorn’s bullish stand on cannabis has borne fruit. SMG’s fiscal Q3 earnings, reported at the end of July, showed a 14% positive surprise – EPS came in at $3.11 against a forecast of $2.71. The Q3 earnings were up 16% from the year-ago quarter. Shares in SMG are up 76% year-to-date.Despite the strong earnings and the increasing sales in grow supplies, the most recent analyst takes on SMG are exact opposites. Merrill Lynch’s Christopher Carey gives the stock a Sell rating, and a low price target of $96. He bases his stance on the declining outlook in cannabis stocks over the last two quarters.5-star analyst William Chappell, of SunTrust Robinson, sees a better future for SMG. He gives the stock a Buy rating, raised his price target by 20%, to $120. He writes, “The continued profitability progression in the Hawthorne segment is an important factor for the stock in quarters to come.” Chappell’s price target suggests a 10% upside to SMG stock.Shares in SMG are selling for $108.50, just above the $108 average target. SMG is up 5.6% since its July 31 Q3 earnings report. KushCo Holdings, Inc. (KSHB)Land and growing facilities aren’t the only support services that the cannabis industry needs. Containers, packaging, and vaporizer products are essential for the medical cannabis segment, for shipping the product and for customer use. KushCo fills this need for the industry.Supporting the cannabis industry has been lucrative. KushCo reported record earnings in its fiscal Q3, of $41.5 million. On the down side, the company is operating at a loss, and reported a net loss per share of 12 cents. This was an improvement of 2 cents per share from the year-ago quarter. As a mitigating factor to the earnings loss, KushCo reported $21.2 million in available cash in May, a gain of $7.7 million since the start of the company’s fiscal year.Wall Street’s analysts were generally pleased by KSHB’s quarterly performance. Benchmark analyst Mike Hickey saw fit to initiate coverage of the stock with a Buy rating and a $7 price target, suggesting an upside of 83%.Writing from Northland Securities, analyst Greg Gibas gave a clear reason for optimism in KSHB: “We believe KSHB will continue to benefit from growing & deepening its customer relationships while also cross-selling throughout its customer base as the company continues to power the global cannabis ecosystem.” His $8 target implies a high upside of 109%. Scott Fortune, of Ross Capital, also gave the stock an $8 target, and added, “The company reaffirmed its $150M FY19 annual revenue target with an emphasis on doubling revenues next quarter and new states being added to its list. Canada's cannabis 2.0 is also expected to come online in 4Q19 and contribute meaningfully to its top line.”These three reviews give KSHB its consensus rating of Strong Buy. The average price target, $7.67, suggests an upside potential of 100% from the current share price of $3.82.Visit TipRanks’ Top Stocks page, and find the most recommended stocks from Wall Street’s best analysts.

  • PR Newswire

    Live Investor Conference & Webinar: Cannabis Industry Companies Present September 12th

    Cannabis Company Executives share vision, answer questions live at VirtualInvestorConferences.com NEW YORK , Sept. 6, 2019 /PRNewswire/ -- Virtual Investor Conferences and KCSA Strategic Communications ...

  • CNW Group

    /C O R R E C T I O N from Source -- VirtualInvestorConferences.com/

    /C O R R E C T I O N from Source -- VirtualInvestorConferences.com/

  • Benzinga

    How This Family-Owned Cannabis Business Stays Profitable, Self-Funded Despite Tough Regulatory Environment

    The legalization of cannabis has created a multibillion-dollar market with a huge potential. In the rush to take advantage of this growth, thousands of investors are piling into dozens of public cannabis companies. Luckily, there are plenty of companies to choose from, ranging from large producers like Canopy Growth Corp (NYSE: CGC) and Tilray Inc. (NASDAQ: TLRY to providers of ancillary services like KushCo Holdings Inc (OTC: KSHB) and Innovative Industrial Properties Inc (NYSE: IIPR).

  • ACCESSWIRE

    KushCo Holdings to Present at MJBizCon International

    GARDEN GROVE, CA / ACCESSWIRE / September 4, 2019 / KushCo Holdings, Inc. (OTCQX:KSHB) (''KushCo'' or the ''Company''), today announced that Jason Vegotsky, KushCo’s President and Chief Revenue Officer, ...

  • Bloomberg

    Direct Lenders Are Poised to Pounce If Credit Volatility Extends

    (Bloomberg) -- Direct lenders are preparing to pounce on opportunities in credit markets after turbulence that deterred other investors.The high-yield bond and leveraged-loan markets have been rattled by trade jitters and fears of slowing global growth in August, with a raft of deals scrapped and continued outflows from funds that buy the debt. “This potentially creates pockets of opportunity for private credit,” said Drew Schardt, head of credit at private market investor Hamilton Lane. “The heightened volatility that we’re seeing now creates a bit of a borrower-lender disconnect, and the markets are trying to decide whether what we’re seeing right now is just fleeting volatility or indicative of a fundamental deterioration.”Sponsors are viewing non-bank lenders as “a safe haven -- a credit solution that doesn’t depend on the vagaries of the loan syndication market,” said Randy Schwimmer, head of origination and capital markets at Churchill Asset Management.“Money moving in and out of retail loan funds is not what drives the private debt market,” Schwimmer said. “It’s instead driven by private equity fundraising. That’s the fuel that feeds the financing pipeline for direct lenders. It remains plentiful and we see no signs of that abating.”August DealsPrivate credit investors are not without concerns, a major one being that the business cycle is about to turn. They’re navigating lower interest rates and slowing global growth, while the economy remains strong with low unemployment and a decent performance from borrowers.“Generally, folks want to lean-in to more defensive positions in the current environment,” Hamilton Lane’s Schardt said. “Private lenders are exercising caution in terms of how they’re structuring their deals, in terms of a willingness to move up the capital structure and a desire to shorten duration in some cases.”In some corners of private credit, spreads have even contracted as investors pile in to higher quality names, according to Ted Goldthorpe, head of credit at BC Partners. Unitranche debt for a solid borrower with strong sponsors that may have been priced at 575 to 600 basis points above the Libor benchmark a year ago is now in the 525 to 550 basis-point range, he said.Pricing for first-lien loans has held steady at around 400 to 450 basis points and second liens around 750 to 850 basis points above Libor, Goldthorpe said. Though falling Libor could be a headwind to the asset class, returns in middle market debt could still hit 7% to 9%, he said.“I still think middle market lending is still good relative value compared to other asset classes.” he said.To contact the reporter on this story: Kelsey Butler in New York at kbutler55@bloomberg.netTo contact the editors responsible for this story: Natalie Harrison at nharrison73@bloomberg.net, Sally Bakewell, Dawn McCartyFor more articles like this, please visit us at bloomberg.com©2019 Bloomberg L.P.

  • This Major Health Concern Could Wreak Havoc on the Cannabis Industry’s Growth Potential
    Motley Fool

    This Major Health Concern Could Wreak Havoc on the Cannabis Industry’s Growth Potential

    How well Curaleaf and other pot stocks are able to grow in the U.S. will depend on the perceived risks related to using cannabis, and right now, there are still many questions.

  • KushCo Secures New $50 Million Credit Line
    Motley Fool

    KushCo Secures New $50 Million Credit Line

    The cannabis supplies and packaging company will use the funds to boost its organic growth.

  • ACCESSWIRE

    KushCo Holdings Secures $50 Million Credit Facility from Monroe Capital LLC

    GARDEN GROVE, CA / ACCESSWIRE / August 22, 2019 / KushCo Holdings, Inc. (KSHB) (''KushCo'' or the ''Company''), today announced that it has closed on a $50 million credit facility (the “Facility”) with Monroe Capital LLC (“Monroe”), consisting of a $35 million revolving line of credit and an accordion of up to $15 million that will be available subject to covenant compliance and borrowing base availability. “KushCo continues to execute on its less dilutive financing strategy that will provide the capital necessary to support our continued operations and acquisitive growth,” commented Nick Kovacevich, KushCo’s Chief Executive Officer. “We’re excited to enter this hyper-growth industry with the Company,” commented Ted Koenig, President & CEO of Monroe.

  • ACCESSWIRE

    KushCo Holdings Adds Pete Kadens, Former CEO of Green Thumb Industries, to Advisory Board

    GARDEN GROVE, CA / ACCESSWIRE / August 20, 2019 / KushCo Holdings, Inc. (KSHB) (“KushCo” or the “Company”), today announced that it has added Pete Kadens, the former CEO of Green Thumb Industries, one of the largest publicly-traded cannabis operators in the United States, to its Advisory Board. Mr. Kadens will provide guidance and mentorship on the Company’s strategic vision with corporate development and M&A activities to accelerate and maintain long-term profitable growth. In August 2018, he retired from his position as CEO and Board Director of Green Thumb Industries (GTI).

  • Here's How Shockingly Low the Odds of U.S. Marijuana Legalization Really Are
    Motley Fool

    Here's How Shockingly Low the Odds of U.S. Marijuana Legalization Really Are

    Investors, don't bet on U.S. legalization of pot anytime soon.

  • ACCESSWIRE

    KushCo Holdings Announces Change of Auditor

    GARDEN GROVE, CA / ACCESSWIRE / August 8, 2019 / KushCo Holdings, Inc. (OTCQX:KSHB) (''KushCo'' or the ''Company''), today announced the appointment of Marcum LLP (“Marcum”) as the Company’s new independent ...

  • Benzinga

    KushCo Launches A Service To Connect CBD Companies And National Retailers

    KushCo Holdings Inc (OTC: KSHB) has announced the creation of a new Retail Services division. Benzinga's Cannabis Capital Conference heads to Detroit on Aug. 15 -- Click here to learn more! “The maturation of the cannabis industry has opened up countless avenues for business development across the industry’s supply chain.

  • ACCESSWIRE

    KushCo Holdings Launches New Division to Connect CBD Network to National Retail Chains

    GARDEN GROVE, CA / ACCESSWIRE / August 6, 2019 / KushCo Holdings, Inc. (KSHB) (“KushCo” or the “Company”), announced the creation of their new Retail Services division. The new business unit will focus on providing comprehensive retail solutions, through strategic partnerships with best-in-class sales agencies, to leading CBD brands. KushCo’s retail services division will focus on industry education and compliance, as well as building distribution networks of CBD brands across conventional retail channels.